Reports and Data’s latest market analysis report, titled ‘Global Oral Peptide Therapeutics Market – Forecast to 2026,’ is a comprehensive study of the Oral Peptide Therapeutics industry and provides the targeted readers with vital data & information pertaining to the industry. The report comprises quantitative and qualitative research on...

The global Peptide Based Cancer Therapeutics Market  size is expected to reach USD 516.75 Million in 2028 and register a CAGR of 6.4% over the forecast period, according to a latest report by Reports and Data. Major factors driving market revenue growth are development of advanced peptide synthesizers, availability of funding for R&D, rising number of research activities, and...

The global Peptide Therapeutics Drugs Market  was valued at USD 25.35 billion in 2018 and is expected to reach USD 50.60 billion by the year 2026, at a CAGR of 9.0%. Peptide drugs are used as replacement therapies which supplements peptide hormones when the endogenous levels tend to decrease. The first peptide therapeutic was used to treat diabetic patients in the 19th century....

According to a new report published by UnivDatos Markets Insights, the peptide therapeutics market was valued at USD 25 billion in 2021 & is expected to grow at a CAGR of 9% from 2022-2030. The analysis has been segmented into Drug Type (Branded, and Generic); Route of Administration (Parental, Mucosal, Oral, and Transdermal); Application (Cancer, Metabolic, Cardiovascular Disorders,...

The Antimicrobial peptides Market 2026 report provides detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive landscape, sales analysis, impact of domestic and global Antimicrobial peptides market players, value chain optimization, trade regulations, recent developments, opportunities...